semaglutide elevated liver enzymes Can Cause Damage? Safety Evidence Explained Semaglutide and Fatty Liver Disease:

An overview of once-weekly glucagon-like peptide-1 receptor agonists available efficacy and safety data and perspectives for the future

Although the definition of carnitine insufficiency in liver cirrhosis patients remains unclear, the symptoms of carnitine deficiency are thought to be muscle cramps, general fatigue, hepatic encephalopathy, and hyperammonemia in liver cirrhosis patients

Similarly, a single dose of semaglutide downregulated lung IL-1, TNF, and IL-6 expression in a polymicrobial sepsis-induced lung inflammation model

After 2 weeks of treatment, mice treated with GLP-1MK-801, as well as those subjected to calorie restriction or GLP-1 monotherapy, demonstrated enhanced glucose tolerance compared with mice that were treated with the vehicle or MK-801 monotherapy (Extended Data Fig